These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1455521)

  • 21. Frequency of schistosomiasis mansoni, of its clinicopathological forms and of the ectopic locations of the parasite in autopsies in Belo Horizonte, Brazil.
    Gonçalves EC; Fonseca AP; Pittella JE
    J Trop Med Hyg; 1995 Oct; 98(5):289-95. PubMed ID: 7563253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the permeability of distal splenorenal anastomosis, by ultrasonography and angiography in hepatosplenic form of schistosomiasis mansoni].
    Magalhães AC
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(6):260-6. PubMed ID: 3110904
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intradermal reaction with diluted antigen for the diagnosis of schistosomiasis mansoni: evaluation of sensitivity].
    Pinto PL; Amato Neto V; Matsubara L; de Carvalho SA
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(6):288-90. PubMed ID: 3150865
    [No Abstract]   [Full Text] [Related]  

  • 25. New approaches to the measurement of morbidity in intestinal schistosomiasis.
    Zwingenberger K; de Jonge N; Oellinger H; Feldmeier H
    Trop Med Parasitol; 1989 Jun; 40(2):163-8. PubMed ID: 2505376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IMMUNODIFFUSION STUDIES IN HUMAN SCHISTOSOMIASIS MANSONI. I. HEPATOINTESTINAL AND HEPATOSPLENIC FORMS.
    DA SILVA LC; FERRI RG
    Rev Inst Med Trop Sao Paulo; 1965; 7():1-6. PubMed ID: 14307817
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Capillaria hepatica infection on Schistosoma mansoni challenge in mice.
    el-Nassery SM; el-Gebaly WM
    J Egypt Soc Parasitol; 1992 Aug; 22(2):425-35. PubMed ID: 1500783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
    Botros S; Sayed H; Amer N; El-Ghannam M; Bennett JL; Day TA
    Int J Parasitol; 2005 Jun; 35(7):787-91. PubMed ID: 15925597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMMUNODIFFUSION STUDIES IN HUMAN SCHISTOSOMIASIS MANSONI. II. LOCALIZATION OF ANTIBODIES BY IMMUNOELECTROPHORESIS.
    DA SILVA LC; FERRI RG
    Rev Inst Med Trop Sao Paulo; 1965; 7():7-10. PubMed ID: 14312167
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of schistosomiasis-related morbidity at community level in areas of different endemicity.
    Hatz C; Savioli L; Mayombana C; Dhunputh J; Kisumku UM; Tanner M
    Bull World Health Organ; 1990; 68(6):777-87. PubMed ID: 2127383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual presentation of schistosomiasis duodenitis.
    Witham RR; Mosser RS
    Gastroenterology; 1979 Dec; 77(6):1316-8. PubMed ID: 499718
    [No Abstract]   [Full Text] [Related]  

  • 32. Childhood stunting in Northeast Brazil: the role of Schistosoma mansoni infection and inadequate dietary intake.
    Assis AM; Prado MS; Barreto ML; Reis MG; Conceição Pinheiro SM; Parraga IM; Blanton RE
    Eur J Clin Nutr; 2004 Jul; 58(7):1022-9. PubMed ID: 15220944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
    Sukwa TY; Bulsara MK; Wurapa FK
    J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound and CT changes of liver parenchyma in acute schistosomiasis.
    Cesmeli E; Vogelaers D; Voet D; Duyck P; Peleman R; Kunnen M; Afschrift M
    Br J Radiol; 1997 Jul; 70(835):758-60. PubMed ID: 9245889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatosplenic schistosomiasis.
    Lubeya M; Muloshi C; Baboo KS; Sianongo S; Kelly P
    Lancet; 2010 Nov; 376(9753):1645. PubMed ID: 21075257
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
    Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
    East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mansoni: intensity of infection and morbidity among schoolchildren in Matlapaneng, Ngamiland, Botswana.
    Friis H; Byskov J
    Trop Geogr Med; 1987 Jul; 39(3):251-5. PubMed ID: 3124313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire.
    Raso G; Luginbühl A; Adjoua CA; Tian-Bi NT; Silué KD; Matthys B; Vounatsou P; Wang Y; Dumas ME; Holmes E; Singer BH; Tanner M; N'goran EK; Utzinger J
    Int J Epidemiol; 2004 Oct; 33(5):1092-102. PubMed ID: 15256525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portal hypertension due to hepatosplenic schistosomiasis: a case report and review of the literature.
    Eyres KS; Kantharia B; Magides AD; Ali HH; MacDonald RC
    Br J Clin Pract; 1991; 45(2):146-7. PubMed ID: 1793702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.